1Chiller KG,Passaro D,Frieden IJ.Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex[J].Arch Dermatol,2002,138(12): 1567-1576.
8Greene AK.Systemic corticosteroid is effective and safe treatment for problematic infantile hemangioma [J].Pediatr Dermatol,2010,27(3): 322-323.
9Grover C,Arora P,Kedar A,et al.Combination of oral corticosteroids and polidocanol sclerotherapy in the management of infantile hemangiomas[J].Dermatol Surg,2010,36(12):2030-2036.
6Metry D. Update on hemangiomas of infancy. Curt Opin Pediatr, 2004, 16:373-377.
7Bennett ML, Fleiseher Jr AB, Chamlin SL, et al. Oral eortieosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol, 2001, 137 : 1208-1213.
8Ezekowitz RAB, Mulliken JB, Folkman J. Interferon alpha 2a therapy for life threatening hemangiomas of infancy. N Engl J Med, 1992, 326 : 1456-1463.
9Enjolras O, Breviere GM, Roger G, et al. Vincristine treatment for function-and life-threatening infantile hemangioma. Arch Pediatr, 2004, 11:99-107.
10Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med, 2008, 358:2649-2651.
